NICE backs AstraZeneca’s dual immunotherapy for advanced liver cancer

30th July 2025 Uncategorised 0

Imfinzi and Imjudo combination recommended as first-line treatment

More: NICE backs AstraZeneca’s dual immunotherapy for advanced liver cancer
Source: News